Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ogale SS et al. – The authors found an increased risk of CVEs associated with the use of ipratropium within the past 6 months. These findings are consistent with previous concerns raised about the cardiovascular safety of ipratropium bromide.

Related Articles

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/07/09    Relevance Score: 90%

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/05/09    Relevance Score: 90%

Chronic Obstructive Pulmonary Disease
Internet Source, 10/30/09    Relevance Score: 89%

CAM and Respiratory Disease
Nutrition in Clinical Practice, 10/30/09    Relevance Score: 89%

The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease
Internet Source, 10/09/09    Relevance Score: 89%

Today in Clinical Pharmacology...keeping you current

Resorption and elimination kinetics of benzoic acid during chemical necrectomy in deep burns
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease: A Randomized Controlled Trial
JAMA, 12/17/09

Hemodialysis in Hypotensive Heart Failure Using Midodrine
The American Journal of the Medical Sciences, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address